PDCD1 and type 1 diabetes mellitus: GADA-negative T1DM under anti-PD-1 therapy could be triggered by a sudden and major activation of beta-cell reactive CD8+ T-cell clones without the involvement of humoral immunity in the short time frame before overt diabetes [39].